92 related articles for article (PubMed ID: 30488672)
1. High grade squamous intraepithelial lesion on high-risk HPV negative patients: Why we still need the Pap test.
Sun H; Masand RP; Patel SJ; Padmanabhan V
Diagn Cytopathol; 2018 Nov; 46(11):908-913. PubMed ID: 30488672
[TBL] [Abstract][Full Text] [Related]
2. HPV-ISH-Negative Invasive Cervical Squamous Cell Carcinoma: Histologic and Pap Test Results.
Alexander C; White M; Maleki Z; Rodriguez EF
Acta Cytol; 2019; 63(5):417-423. PubMed ID: 31195388
[TBL] [Abstract][Full Text] [Related]
3. Aptima HPV messenger RNA testing and histopathologic follow-up in women with HSIL cytology: A study emphasizing additional review of HPV-negative cases.
Li A; Li J; Austin RM; Wang T; Ashman D; Zhang H; Matsko J; Zhao C
Cancer Cytopathol; 2021 Aug; 129(8):622-631. PubMed ID: 33764649
[TBL] [Abstract][Full Text] [Related]
4. Low-grade squamous intraepithelial lesion on Papanicolaou test: follow-up rates and stratification of risk for high-grade squamous intraepithelial lesion.
Rufail M; Lew M; Pang J; Jing X; Heider A; Cantley RL
J Am Soc Cytopathol; 2020; 9(4):258-265. PubMed ID: 32402830
[TBL] [Abstract][Full Text] [Related]
5. Histopathologic follow-up and HPV test results with HSIL Papanicolaou test results in China's largest academic women's hospital.
Tao X; Austin RM; Zhang H; Zhang L; Xiao J; Zhou X; Wang L; Zhao C
Cancer Cytopathol; 2017 Dec; 125(12):947-953. PubMed ID: 28885778
[TBL] [Abstract][Full Text] [Related]
6. Risk of HSIL (CIN 2-3) on colposcopic biopsy is minimal in postmenopausal women with LSIL on cytology and a negative HRHPV test.
Ozturk M; Umudum H; Alanbay I; Ulubay M; Fidan U; Dede M; Yenen MC
Diagn Cytopathol; 2016 Dec; 44(12):969-974. PubMed ID: 27527826
[TBL] [Abstract][Full Text] [Related]
7. High-grade squamous intraepithelial lesion cervicovaginal paps with negative high-risk HPV testing, a prospective study with histological follow-up.
Agoff SN; Brockmeyer AD; Barrie AM; Larson J
Diagn Cytopathol; 2023 Aug; 51(8):475-479. PubMed ID: 37086174
[TBL] [Abstract][Full Text] [Related]
8. Immediate risk of HSIL presence in women who have both ASC-US cytology and negative high-risk HPV test.
Ozturk M; Umudum H; Aydin A; Ulubay M; Keskin U; Dede M; Yenen MC
Eur J Gynaecol Oncol; 2016; 37(2):232-7. PubMed ID: 27172751
[TBL] [Abstract][Full Text] [Related]
9. HPV genotyping for triage of women with abnormal cervical cancer screening results: a multicenter prospective study.
Nakamura Y; Matsumoto K; Satoh T; Nishide K; Nozue A; Shimabukuro K; Endo S; Nagai K; Oki A; Ochi H; Morishita Y; Noguchi M; Yoshikawa H
Int J Clin Oncol; 2015 Oct; 20(5):974-81. PubMed ID: 25652908
[TBL] [Abstract][Full Text] [Related]
10. HPV status in women with high-grade dysplasia on cervical biopsy and preceding negative HPV tests.
Ge Y; Mody RR; Olsen RJ; Zhou H; Luna E; Armylagos D; Puntachart N; Hendrickson H; Schwartz MR; Mody DR
J Am Soc Cytopathol; 2019; 8(3):149-156. PubMed ID: 31097291
[TBL] [Abstract][Full Text] [Related]
11. CADM1, MAL, and miR124 Promoter Methylation as Biomarkers of Transforming Cervical Intrapithelial Lesions.
Del Pino M; Sierra A; Marimon L; Martí Delgado C; Rodriguez-Trujillo A; Barnadas E; Saco A; Torné A; Ordi J
Int J Mol Sci; 2019 May; 20(9):. PubMed ID: 31067838
[TBL] [Abstract][Full Text] [Related]
12. Punch biopsy guided by both colposcopy and HR-HPV status is more efficient for identification of immediate high-grade squamous intraepithelial lesion or worse among HPV-infected women with atypical squamous cells of undetermined significance.
Ding Z; Li Y; Chen A; Song M; Zhang Y
Eur J Obstet Gynecol Reprod Biol; 2016 Dec; 207():32-36. PubMed ID: 27816739
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the diagnostic value of cervical cytology and HPV HR DNA testing for the diagnosis of low-grade and high-grade squamous intraepithelial lesions across different age groups.
Paluszkiewicz A; Pruski D; Iwaniec K; Kędzia W
Ginekol Pol; 2017; 88(3):141-146. PubMed ID: 28397203
[TBL] [Abstract][Full Text] [Related]
14. Age-specific HPV type distribution in high-grade cervical disease in screened and unvaccinated women.
Aro K; Nieminen P; Louvanto K; Jakobsson M; Virtanen S; Lehtinen M; Dillner J; Kalliala I
Gynecol Oncol; 2019 Aug; 154(2):354-359. PubMed ID: 31176553
[TBL] [Abstract][Full Text] [Related]
15. Management of atypical squamous cells of undetermined significance or low-grade squamous intraepithelial lesions of the uterine cervix with human papilloma virus infection among young women aged less than 25 years.
Ryu KJ; Lee S; Min KJ; Hong JH; Song JY; Lee JK; Lee NW
Diagn Cytopathol; 2016 Dec; 44(12):959-963. PubMed ID: 27714942
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic accuracy of high-risk HPV genotyping in women with high-grade cervical lesions: evidence for improving the cervical cancer screening strategy in China.
Xu H; Lin A; Shao X; Shi W; Zhang Y; Yan W
Oncotarget; 2016 Dec; 7(50):83775-83783. PubMed ID: 27626178
[TBL] [Abstract][Full Text] [Related]
17. Adjunctive high-risk human papillomavirus DNA testing is a useful option for disease risk assessment in patients with negative Papanicolaou tests without an endocervical/transformation zone sample.
Zhao C; Austin RM
Cancer; 2008 Aug; 114(4):242-8. PubMed ID: 18484643
[TBL] [Abstract][Full Text] [Related]
18. Low-Grade Squamous Intraepithelial Lesion or High-Grade Squamous Intraepithelial Lesion? Concordance Between the Interpretation of Low-Grade Squamous Intraepithelial Lesion and High-Grade Squamous Intraepithelial Lesion in Papanicolaou Tests: Results From the College of American Pathologists PAP Education Program.
Crothers BA; Ghofrani M; Zhao C; Dodd LG; Goodrich K; Husain M; Kurtycz DFI; Russell DK; Shen RZ; Souers RJ; Staats PN; Tabatabai ZL; Witt BL; Davey DD
Arch Pathol Lab Med; 2019 Jan; 143(1):81-85. PubMed ID: 30133317
[TBL] [Abstract][Full Text] [Related]
19. HPV16 genotype, p16/Ki-67 dual staining and koilocytic morphology as potential predictors of the clinical outcome for cervical low-grade squamous intraepithelial lesions.
Vrdoljak-Mozetič D; Krašević M; Verša Ostojić D; Štemberger-Papić S; Rubeša-Mihaljević R; Bubonja-Šonje M
Cytopathology; 2015 Feb; 26(1):10-8. PubMed ID: 24261348
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the performance of the NucliSENS EasyQ HPV E6/E7 mRNA assay and HPV DNA chip for testing squamous cell lesions of the uterine cervix.
Munkhdelger J; Choi Y; Lee D; Kim S; Kim G; Park S; Choi E; Jin H; Jeon BY; Lee H; Park KH
Diagn Microbiol Infect Dis; 2014 Aug; 79(4):422-7. PubMed ID: 24856365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
